Prediction Case File
YouTubeTracking Live

2 Stocks I’m Buying this week!

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
23 Aug 2026, 13:29 UTC
Recorded by Tahlil Plus
23 Aug 2026, 14:29 UTC
Video preview for 2 Stocks I’m Buying this week!
Source overview

AI-generated source summary

The video identifies two key stock purchases: Royal Gold (RGLD) and GFL Environmental (GFL). For RGLD, the analysis suggests a bullish outlook, with a current price around $202.24 and a target of $250.0. The fail-bound for this bullish setup is identified at $180.0. For GFL, the current price is around $41.05, with a bullish sentiment and a target price of $50.0. The fail-bound for GFL is estimated at $35.0. The timeframe for these analyses appears to be medium-term, likely swing trading. The underlying reasoning for RGLD focuses on its performance against broader market trends and its perceived value. For GFL, the analysis highlights its business model as recession-proof and its strong growth metrics in revenue, adjusted EBITDA, and free cash flow, supported by a strategy of organic growth and acquisitions. The valuation multiples for GFL are noted as being relatively low compared to peers, suggesting potential upside. The data center development potential in West Texas is also mentioned as a significant growth catalyst for TPL, leveraging abundant land, water, and energy resources.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
311
Historical success
34.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail